Literature DB >> 10634156

Congenital hepatic fibrosis in Indian children.

U Poddar1, B R Thapa, R K Vashishta, C S Girish, K Singh.   

Abstract

BACKGROUND: Congenital hepatic fibrosis (CHF) is an uncommon cause of portal hypertension in children. So far, there is no report of this from the subcontinent. We have studied the clinical spectrum of CHF in North Indian children.
METHODS: Fifteen children were diagnosed with CHF on the basis of their liver histology over a period of 6.5 years. Their clinical details were recorded. Oesophagogastroduodenoscopy and abdominal ultrasonography were performed in all cases. All siblings were examined clinically; and ultrasonography, endoscopy and liver biopsy were performed if there was firm hepatomegaly. Children with variceal bleeding were managed by endoscopic sclerotherapy. The median age of these children was 8 years with a male to female ratio of 1.5:1.
RESULTS: Only one sibling (of 33) was diagnosed as having CHF. The predominant presentations were variceal bleeding in six, abdominal distension in seven and incidental detection of organomegaly in two. Hepatomegaly was present in all patients and splenomegaly in all but one. Liver function and renal function tests were normal in all children, except for a raised serum alkaline phosphatase in six. Two children had associated renal cysts, two had choledochal cysts, one each had Caroli's disease and biliary atresia and two children had portal vein thrombosis. Variceal obliteration was achieved in five children after an average 4.8 sclerotherapy sessions and one required a mesocaval shunt. On follow up (median 41 months, range 1-80 months) all are doing well.
CONCLUSIONS: Congenital hepatic fibrosis is mainly sporadic in India and associated renal lesions are uncommon. Endoscopic sclerotherapy is effective in controlling variceal bleed and the prognosis is universally good in the absence of renal diseases.

Entities:  

Mesh:

Year:  1999        PMID: 10634156     DOI: 10.1046/j.1440-1746.1999.02028.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  Brush border enzymes and absorptive capacity in extrahepatic portal venous obstruction in children.

Authors:  Gurbakhshish Singh Sidhu; B R Thapa; Pawan Rawal; K K Prasad; C K Nain; B Nagi; Kartar Singh
Journal:  Hepatol Int       Date:  2010-09-05       Impact factor: 6.047

2.  β-Blocker therapy ameliorates hypersplenism due to portal hypertension in children.

Authors:  Ujjal Poddar; Upender Shava; Surender Kumar Yachha; Jaya Agarwal; Sheo Kumar; Sanjay S Baijal; Anshu Srivastava
Journal:  Hepatol Int       Date:  2014-09-23       Impact factor: 6.047

Review 3.  Management of portal hypertension.

Authors:  S K Yachha; Kamal Chetri; Richa Lal
Journal:  Indian J Pediatr       Date:  2002-09       Impact factor: 1.967

Review 4.  Is portal vein cavernous transformation a component of congenital hepatic fibrosis?

Authors:  Ozlem Yonem; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

5.  A Family of Congenital Hepatic Fibrosis and Atypical Retinitis Pigmentosa.

Authors:  Sunil Pawar; Vinay Zanwar; Ashok Mohite; Ravindra Surude; Pravin Rathi; Meenakshi Balasubramani
Journal:  Clin Pract       Date:  2015-11-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.